Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 20 2024
0mins
Should l Buy ?
Source: Benzinga
Fluor Corporation Fourth Quarter Results:
- Shares of Fluor Corporation fell after posting adjusted earnings of 68 cents per share, beating market estimates.
- Quarterly sales were $3.82 billion, lower than the expected $4.11 billion, leading to a 7.7% decline in shares.
Stocks Movement:
- TRxADE HEALTH, Inc., AgriFORCE Growing Systems Ltd., Monopar Therapeutics Inc., and Biofrontera Inc. saw significant stock price increases.
- Companies like Barclays PLC, VIZIO Holding Corp., and Discover Financial Services experienced notable stock surges.
- On the other hand, RAPT Therapeutics, MicroCloud Hologram Inc., and Summit Therapeutics Inc. faced substantial declines in their stock prices.
Other Stock Movements:
- Various companies such as Biotricity, Inc., Shineco, Inc., and Iovance Biotherapeutics, Inc. witnessed positive stock movements.
- Conversely, companies like Better Therapeutics, Inc., AirNet Technology Inc., and Evolv Technologies Holdings, Inc. saw declines in their stock prices.
Market News:
- Ethereum surpassed $2,900, with Starknet and Filecoin among the top gainers in the market.
Industry Updates:
- WuXi Advanced Therapies received FDA approval for analytical testing and manufacturing, impacting Iovance Biotherapeutics'
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
